A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: an analysis of the ATHENA trial.

A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: an analysis of the ATHENA trial.

Item
http://www.wikidata.org/entity/Q30317232
Liver Metastasis of a Triple-Negative Breast Cancer and Complete Remission for 5 Years After Treatment With Combined Bevacizumab/Paclitaxel/Carboplatin: Case Report and Review of the LiteratureLocally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?Clinical outcomes among HR+/HER2- metastatic breast cancer patients with multiple metastatic sites: a chart review study in the US.Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids.Bevacizumab: a review of its use in advanced cancer.Role of everolimus in the treatment of metastatic HER2-negative/HR-positive breast cancer.A Delphi consensus and open debate on the role of first-line bevacizumab for HER2-negative metastatic breast cancer.A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM).Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study.Predictive value of angiogenesis-related gene profiling in patients with HER2-negative metastatic breast cancer treated with bevacizumab and weekly paclitaxel.
P2860

A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: an analysis of the ATHENA trial.

Item
http://www.wikidata.org/entity/Q30317232
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A prognostic factor index for ...... analysis of the ATHENA trial.
@ast
A prognostic factor index for ...... analysis of the ATHENA trial.
@en
type
label
A prognostic factor index for ...... analysis of the ATHENA trial.
@ast
A prognostic factor index for ...... analysis of the ATHENA trial.
@en
prefLabel
A prognostic factor index for ...... analysis of the ATHENA trial.
@ast
A prognostic factor index for ...... analysis of the ATHENA trial.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
A prognostic factor index for ...... n analysis of the ATHENA trial
@en
P2093
P304
P31
P356
10.1016/J.BREAST.2014.06.017
P433
P478
P50
P577
P698
P921